Table 1.
Baseline characteristics of participants.
| Variable | alive | dead | p-value | |
|---|---|---|---|---|
| N=729 | N=270 | |||
| age | 56.29 (14.42) | 66.05 (15.62) | <0.001 | |
| sex | female | 327 (44.9%) | 105 (38.9%) | 0.098 |
| male | 402 (55.1%) | 165 (61.1%) | ||
| Family history | negative | 676 (92.7%) | 215 (79.6%) | <0.001 |
| positive | 53 (7.3%) | 55 (20.4%) | ||
| smoking | no | 612 (84.0%) | 149 (55.2%) | <0.001 |
| yes | 117 (16.0%) | 121 (44.8%) | ||
| background disorder | no | 528 (72.4%) | 68 (25.2%) | <0.001 |
| yes | 201 (27.6%) | 202 (74.8%) | ||
| metastasis | negative | 686 (94.1%) | 135 (50.0%) | <0.001 |
| positive | 43 (5.9%) | 135 (50.0%) | ||
| exercise | no | 698 (95.7%) | 269 (99.6%) | <0.001 |
| yes | 31 (4.3%) | 1 (0.4%) | ||
| occupation | disable | 1(0.14) | 10(3.70) | <0.001 |
| freelance | 118(16.19) | 37(13.70) | ||
| retired | 109(14.95) | 45(16.67) | ||
| jobless | 151(20.71) | 72(26.67) | ||
| housekeeper | 310(42.52) | 96(35.56) | ||
| studying | 7(0.96) | 1(0.37) | ||
| employee | 33(4.53) | 9(3.33) | ||
| tumor place | appendix | 3(0.41%) | 1(0.37%) | <0.001 |
| pancreas | 29(3.98%) | 78(28.89%) | ||
| small intestine | 1(0.14%) | 0(0.00%) | ||
| rectum | 56(7.68%) | 12(4.44%) | ||
| esophagus | 60(8.23%) | 16(5.93%) | ||
| gastric | 209(28.67%) | 45(16.67%) | ||
| neuroendocrine | 0(0.00%) | 1(0.37%) | ||
| hepatoblastoma | 8(1.10%) | 2(0.74%) | ||
| liver | 43(5.90%) | 20(7.41%) | ||
| colon | 299(41.02%) | 90(33.33%) | ||
| gallbladder | 21(2.88) | 5(1.85) |